Home › Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis › California
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis clinical trials in California
4 studies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis are looking for participants at sites in California.
Cities in California
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
- Palo Alto Medical Foundation Fremont, Fremont
- The Nephrology Group, Fresno
- Providence Medical Foundation, Fullerton
- and 4 more
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Sep 30, 2026 · NCT06072482FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT07800871A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Orange
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- and 2 more
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.